[1]
Wollenberg, A. et al. 2022. Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis. Acta Dermato-Venereologica. 102, (May 2022), adv00726. DOI:https://doi.org/10.2340/actadv.v102.854.